1202407-34-8Relevant articles and documents
TREATMENT OF DISEASES BY EPIGENETIC REGULATION
-
Paragraph 0526; 0527, (2013/11/05)
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of diseases or disorders that are susceptible to administration of a BET inhibitor.
METHODS OF PREPARING QUINAZOLINONE DERIVATIVES
-
Page/Page column 19, (2010/01/30)
The present disclosure relates to methods for preparing compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-l), and in the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.